tyrosyl-glycyl-glycine has been researched along with Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bojková, B; Demečková, V; Gancarčiková, S; Hrčková, G; Kassayová, M; Mudroňová, D; Solár, P | 1 |
| Armstrong, K; Banerjee, N; Ghilchick, M; Parish, DC; Reed, MJ | 1 |
2 other study(ies) available for tyrosyl-glycyl-glycine and Breast Neoplasms
| Article | Year |
|---|---|
Immodin and its immune system supportive role in paclitaxel therapy of 4T1 mouse breast cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Immune System; Leukocytes; Lymphocytes; Lymphokines; Mice; Mice, Inbred BALB C; Monocytes; Paclitaxel | 2017 |
Neutral endopeptidase activity in breast cysts.
Topics: Breast Neoplasms; Enkephalin, Methionine; Female; Fibrocystic Breast Disease; Humans; Leucyl Aminopeptidase; Neprilysin; Oligopeptides; Spectrometry, Fluorescence; Substrate Specificity | 1996 |